Evidence map›Paper›PMID 34996915›Full record

ArticleScientific reports2022

Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.

Cassady Palmer, Vien T Truong, Jeremy A Slivnick, Sarah Wolking, Paige Coleman, Wojciech Mazur, Karolina M Zareba

Open access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Current Perspectives on Atrial Amyloidosis: A Narrative Review.Reviews in cardiovascular medicine · 2024
    Review
  6. Article
  7. Article
  8. [Cardiac arrhythmias and amyloidosis].Archivos peruanos de cardiologia y cirugia cardiovascular
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Cassady PalmerThe Christ Hospital Health Network, 2123 Auburn Ave, Ste 138, Cincinnati, OH, 45219, USA. Cassady.Palmer@thechristhospital.com.
Vien T TruongThe Christ Hospital Health Network, 2123 Auburn Ave, Ste 138, Cincinnati, OH, 45219, USA.
Jeremy A SlivnickThe Ohio State University Wexner Medical Center, Columbus, OH, USA.
Sarah WolkingThe Christ Hospital Health Network, 2123 Auburn Ave, Ste 138, Cincinnati, OH, 45219, USA.
Paige ColemanThe Christ Hospital Health Network, 2123 Auburn Ave, Ste 138, Cincinnati, OH, 45219, USA.
Wojciech MazurThe Christ Hospital Health Network, 2123 Auburn Ave, Ste 138, Cincinnati, OH, 45219, USA.
Karolina M ZarebaThe Ohio State University Wexner Medical Center, Columbus, OH, USA.
Christ Hospital · USHealth Net · USThe Ohio State University Wexner Medical Center · USLindner Center of HOPE · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To determine the differences in left atrial (LA) function and geometry assessed by cardiac magnetic resonance (CMR) between transthyretin (ATTR) and immunoglobulin light chain (AL) cardiac amyloidosis (CA). We performed a retrospective analysis of 54 consecutive patients (68.5% male, mean age 67 ± 11 years) with confirmed CA (24 ATTR, 30 AL) who underwent comprehensive CMR examinations. LA structural and functional assessment including LA volume, LA sphericity index, and LA strain parameters were compared between both subtypes. In addition, 15 age-matched controls were compared to all groups. Patients with ATTR-CA were older (73 ± 9 vs. 62 ± 10 years, p < 0.001) and more likely to be male (83.3% vs. 56.7%, p = 0.036) when compared to AL-CA. No significant difference existed in LA maximum volume and LA sphericity index between ATTR-CA and AL-CA. LA minimum volumes were larger in ATTR-CA when compared with AL-CA. There was a significant difference in LA function with worse strain values in ATTR vs AL: left atrial reservoir [7.4 (6.3-12.8) in ATTR vs. 13.8 (6.90-24.8) in AL, p = 0.017] and booster strains [3.6 (2.6-5.5) in ATTR vs. 5.2 (3.6-12.1) in AL, p = 0.039]. After adjusting for age, LA reservoir remained significantly lower in ATTR-CA compared to AL-CA (p = 0.03), but not LA booster (p = 0.16). We demonstrate novel differences in LA function between ATTR-CA and AL-CA despite similar LA geometry. Our findings of more impaired LA function in ATTR may offer insight into higher AF burden in these patients.

Indexed as

Atrial Function, LeftAtrial RemodelingMagnetic Resonance Imaging, CineAgedAged, 80 and overAmyloid Neuropathies, FamilialAtrial FibrillationCardiomyopathiesFemaleHeart AtriaHumansImmunoglobulin Light-chain AmyloidosisMaleMiddle AgedPredictive Value of TestsRetrospective Studies

Identifiers

PMID34996915
PMCPMC8742089
OpenAlexW4206311870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.